Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 February 2014

During its February 2014 meeting, the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) did not initiate or conclude a safety referral. The Committee focused on the broad spectrum of its responsibilities which cover all aspects of the risk management of the use of medicines.

• Primary Source

ESO: Background information: Press Release: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 6-9 January 2014 http://www.europeansources.info/record/press-release-meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-6-9-january-2014/

---